Fig 1.
Screening flow chart for the systematic review and metaanalysis.
It includes selecting and exclusion reasons which followed Preferred Reporting Items for Systematic Review and Metaanalysis (PRISMA) statement.
Table 1.
Basic characteristics of the included studies.
Fig 2.
Duration of hospital stay of East-Asian Covid-19 patients treated with ACEI/ARB vs. untreated subjects.
The duration of hospital stay data of MD and 95% CI from 9 studies were pooled in this meta-analysis and the result of metaanalysis was described as a forest plot. (a) The whole group analysis; (b)The subgroup analysis of age;(c) The subgroup analysis of gender.
Table 2.
Clinical outcomes of East-Asian Covid-19 patients treated with ACEI/ARB vs. untreated subjects (all studies).
Fig 3.
Severity of East-Asian Covid-19 patients treated with ACEI/ARB vs. untreated subjects.
The severity data of OR and 95% CI from 17 studies were pooled in this meta-analysis and the result of meta-analysis was described as a forest plot. (a) The whole group analysis; (b) The subgroup analysis of age; (c) The subgroup analysis of gender.
Fig 4.
Mortality of East-Asian Covid-19 patients treated with ACEI/ARB vs. untreated subjects.
All-cause mortality data of OR and 95% CI from 23 studies were pooled in this meta-analysis and the result of meta-analysis was described as a forest plot. (a) The whole group analysis; (b) The subgroup analysis of age; (c) The subgroup analysis of gender.
Fig 5.
Mortality of East-Asian Covid-19 patients treated with ACEI/ARB vs. untreated subjects (HT subgroup).
All-cause mortality data of OR and 95% CI from 20 studies were pooled in this meta-analysis and the result of meta-analysis was described as a forest plot. (a) The whole group analysis; (b) The subgroup analysis of age; (c) The subgroup analysis of gender.
Fig 6.
Severity of East-Asian Covid-19 patients treated with ACEI/ARB vs. untreated subjects (HT subgroup).
The severity data of OR and 95% CI from 15 studies were pooled in this meta-analysis and the result of meta-analysis was described as a forest plot. (a) The whole group analysis; (b) The subgroup analysis of age; (c) The subgroup analysis of gender.
Table 3.
Clinical outcomes of East-Asian Covid-19 patients treated with ACEI/ARB vs. untreated subjects (HT subgroup).